Transtek(SZ:300562) Zheng Quan Zhi Xing·2025-08-15 12:16Core Viewpoint - The company plans to dissolve its wholly-owned subsidiary, Loxin Medical Remote Technology (Zhuhai) Co., Ltd., to enhance management efficiency, optimize internal structure, and reduce management costs [2]. Group 1: Company Actions - The decision to dissolve the subsidiary was approved during the third meeting of the fifth board of directors on August 14, 2025 [2]. - The dissolution does not require shareholder approval as it falls within the board's decision-making authority [2]. - The subsidiary's business operations have already been taken over by the company, indicating a strategic consolidation of resources [2]. Group 2: Financial Overview - As of June 30, 2025, the total assets of the company were approximately 273.19 million yuan, compared to 274.23 million yuan as of December 31, 2024 [2]. - The company reported a net loss of approximately 1.04 million yuan for the first half of 2025, a significant improvement from a net loss of 21.12 million yuan for the entire year of 2024 [2]. - The dissolution is expected to have no substantial impact on the company's financial condition or operational results [2].